• EE519 Hereditary Transthyretin Amyloidosis (ATTRv) Below the Age of 70 Healthcare Resource Utilization and Mortality

    Dec 1, 2025, 00:00

  • EE575 Medicare Reimbursements Following Confirmatory MRI-Guided Biopsy vs. Systematic Biopsy Only in Low-Risk and Favorable Intermediate-Risk Prostate Cancer: A Real-World Cost Analysis Among Elderly Medicare Beneficiaries

    Dec 1, 2025, 00:00

  • PCR165 Navigating Uncertainty and Pragmatic Acceptan Canadian Patient and Public Perspectives on Radiopharmaceutical Therapy in the Context of Whole Health

    Dec 1, 2025, 00:00

  • EE117 Burden Of Disease, Healthcare Resource Use and Costs of Respiratory Syncytial Virus Among Adults in Spain in 2021-2023 in the Hospital Setting: A Real-World Retrospective Observational Study of Four Hospitals

    Dec 1, 2025, 00:00

  • HPR64 Drivers and Barriers of Biosimilar Uptake in APAC

    Dec 1, 2025, 00:00

  • EPH161 Methodological Approach to Assess the Environmental Impact Analysis of Expanding Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i) in the Chronic Kidney Disease Patient Pathway: A French Perspective

    Dec 1, 2025, 00:00

  • EPH222 Suicide in Prehospital Practice

    Dec 1, 2025, 00:00

  • PCR253 Understanding Patient Priorities in Psoriasis Treatment: A Review of Key Decision-Making Drivers

    Dec 1, 2025, 00:00

  • CO79 Early Change in Proteinuria as a Surrogate Endpoint in Studies of IgA Nephropathy: An Updated Patient-Level Meta-Analysis and Discussion of Appropriate Methodology

    Dec 1, 2025, 00:00

  • RWD49 Data Linkage in Practi A Living Systematic Review of Clinical Trials in the United States (US) Utilizing Linkage to Real-World Data

    Dec 1, 2025, 00:00

  • EE745 Unveiling the Economic Landscape: Burden of HR/HER2 Locally Recurrent Inoperable or Metastatic Breast Cancer

    Dec 1, 2025, 00:00

  • EE447 Evaluating the Societal and Economic Impact of Immunotherapy for Melanoma Treatment in Bulgaria

    Dec 1, 2025, 00:00

  • PCR216 Significant Burden of Chronic Obstructive Pulmonary Disease (COPD) on Health Status and Well-Being Persists Among Patients Experiencing One Severe or Two or More Moderate Exacerbations of COPD (ECOPD) and Their Caregivers (CGs)

    Dec 1, 2025, 00:00

  • PCR6 A Methodological Review of WOMAC to EQ-5D Mapping Algorithms in Knee Osteoarthritis

    Dec 1, 2025, 00:00

  • MSR113 From Unstructured Text to Enriched Data: Evaluating Large Language Models for Clinical Information Extraction From Echocardiogram Reports

    Dec 1, 2025, 00:00

  • CO97 Enterocutaneous Fistula (ECF) and Economic Burden Preliminary Data From a HEOR Model of a Laboratory (LAB) Experiment Plus Potential Cost Avoidance

    Dec 1, 2025, 00:00

  • EE705 The Economic Impact of Time-to-Target-Temperature of Different Surface Cooling Technologies for Temperature Management in Critically Ill Patients: A Systematic Review, Analysis, and Model

    Dec 1, 2025, 00:00

  • EE454 Experience of Single Dose IV Iron (Ferric Derisomaltose) Use in a Rural District General Medicine Ambulatory Unit and Overview of Its Economic and Sustainability Impact

    Dec 1, 2025, 00:00

  • EPH232 The Cost of Inaction: Strengthening Nutrition in Frailty Guidelines Across Europe

    Dec 1, 2025, 00:00

  • EE411 Enhancing Operational Efficiency: Time and Cost Savings of a Minimally Invasive Vascular Closure Device in Germany

    Dec 1, 2025, 00:00

  • PCR77 Equivalence of Measurement Properties of the Dermatology Life Quality Index (DLQI) Across 13 European Countries

    Dec 1, 2025, 00:00

  • MSR200 The Natural History of Pancreatic Cancer and the Effectiveness of Screening a Model-Based Analysis

    Dec 1, 2025, 00:00

  • EPH126 Higher Mortality for Generalized Pustular Psoriasis Compared With Plaque Psoriasis Highlights the Need for Improved Treatments: Insights From a Meta-Analysis

    Dec 1, 2025, 00:00

  • HPR204 The Impact of the Introduction of Diagnosis-Related Groups (DRG)-Based Hospital Financing on the Performance of Romanian Hospitals

    Dec 1, 2025, 00:00

  • MSR60 Comparison EQ-5D-Y-3L Responses Between Child Self-Reports and Caregiver Proxy Reports

    Dec 1, 2025, 00:00

  • PCR163 Multiple Myeloma Caregiver Costs and Disabilities Data for Economic Modeling and HTA Submissions

    Dec 1, 2025, 00:00

  • HTA253 NICE Guidance, Not-So-NICE Realities: Resource Constraints in HTA

    Dec 1, 2025, 00:00

  • EPH36 Cardiovascular Event Rates and Mortality Among Secondary-Prevention Hypercholesterolemia Patients in Japan

    Dec 1, 2025, 00:00

  • MSR30 Applying G-methods to Account for Treatment Switching in Postmarketing Effectiveness Evaluation: A Case Study of GLP-1 Receptor Agonists for Diabetic Kidney Disease

    Dec 1, 2025, 00:00

  • SA91 Targeted Literature Review Examining the Inclusion of Caregiver Costs and Quality of Life in Published Economic Models for Neurological Conditions

    Dec 1, 2025, 00:00

  • MSR94 Evaluating the Impact of International Drug Pricing Strategies on Indian State-Level

    Dec 1, 2025, 00:00

  • HTA211 Is NICE’s Proportionate Approach Achieving Its Objective: Analysis of Time to Access for Cost Comparison vs. Single Technology Appraisal

    Dec 1, 2025, 00:00

  • EE678 Systematic Review of Decision-Analytic Models Estimating the Economic Impact of Prescription Opioid Use and Associated Adverse Events

    Dec 1, 2025, 00:00

  • CO121 External Control Arm for PHAROS Trial Patients With Metastatic BRAF V600e Mutated NSCLC Treated With First-Line Encorafenib Plus Binimetinib Using Real-World Data From the French ESME Lung Cancer Database (ERASME STUDY)

    Dec 1, 2025, 00:00

  • PCR12 A Targeted Review of Caregiver Experiences of CAR-T Therapy in Ambulatory Settings

    Dec 1, 2025, 00:00

  • EPH175 Patient-Relevant Benefits From Ixekizumab Treatment in Patients With Psoriasis: Data From the German National Psoriasis Registry PsoBest

    Dec 1, 2025, 00:00

  • EE670 Spinal Muscular Atrophy Treatments in Fran What Are the Organizational Economic and Environmental Impacts of Oral and Intrathecal Administrations

    Dec 1, 2025, 00:00

  • P33 Associations Between Undernutrition and Healthcare Utilization and Costs in Community-Dwelling Adults: A Longitudinal Observational Study

    Dec 1, 2025, 00:00

  • MSR13 Accumulating Eviden When Publication Bias Persists

    Dec 1, 2025, 00:00

  • EE208 Cost-Effectiveness Analysis of Intermittently Scanned Continuous Glucose Monitoring in Individuals With Type 2 Diabetes Using Insulin in Sweden: A National Real-World Evidence Perspective

    Dec 1, 2025, 00:00

  • CO155 Inter-Version Comparison of the Boston Carpal Tunnel Questionnaire: A Clinical Validation Study of the Decision Tree-Based Version

    Dec 1, 2025, 00:00

  • EE584 Modeling Early vs. Late Intervention Strategies: The Case of Dupilumab in Children With Severe Atopic Dermatitis

    Dec 1, 2025, 00:00

  • EE433 Evaluating the Annual Cost of Progression in CD30+ Cutaneous T-cell Lymphomas Following 2L+ Systemic Treatment in Italy

    Dec 1, 2025, 00:00

  • HPR93 Fair Pricing of Innovative Medicines From Definition to Application in CAR-T Cell Therapy

    Dec 1, 2025, 00:00

  • EE203 Cost-Effectiveness Analysis of Health2Sync Application With Patient Management Program Compared to Traditional Care for Patients With Type 2 Diabetes Mellitus in Taiwan

    Dec 1, 2025, 00:00

  • SA7 Adjusting to Nonoverlapping Variables in the Unanchored Matching-Adjusted Indirect Comparisons of Survival Outcomes: Application of Monte Carlo Simulations

    Dec 1, 2025, 00:00

  • SA23 Correspondence Between Patients' and Neurologists' Satisfaction With Treatment in Patients With CIDP: Results From a Real-World International Survey

    Dec 1, 2025, 00:00

  • CO205 Real-World Evidence on the Broader Benefits of GLP-1RA-Based Therapies: A Global Targeted Literature Review

    Dec 1, 2025, 00:00

  • EPH100 Examining The Relationship Between Diabetes Mellitus and Eating Disorders

    Dec 1, 2025, 00:00

  • PCR143 Investigating the Importance of EQ-5D Domains and Two Bolt-on Items: How Do the Preferences of People With Acute Leukemia Differ From the General Population?

    Dec 1, 2025, 00:00

  • EE93 Budget Impact Analysis of Ondansetron Oral Dissolving Film vs. Oral Solution in the Chemotherapy-Induced Nausea and Vomiting for Egyptian Pediatric Patients

    Dec 1, 2025, 00:00

  • HSD83 Patterns Of Adoption And Diffusion Of Biological Therapies In Inflammatory Bowel Disease: Patient-Centric Insights From Israel

    Dec 1, 2025, 00:00

  • RWD20 Assessing the Clinical and Economic Burden of Surgical Bleeding in Switzerland

    Dec 1, 2025, 00:00

  • MT6 Assessing Different Procurement Models for Automated Insulin Delivery (AID) Systems Using a Multicriteria Decision Analysis (MCDA)-Based Framework

    Dec 1, 2025, 00:00

  • CO196 Qualitative Literature Review Exploring the Patient Experience of Shortness of Breath in COPD and Asthma

    Dec 1, 2025, 00:00

  • EPH254 The Role of Body Fat in the Regulation of Male Fertility

    Dec 1, 2025, 00:00

  • PCR30 Beyond the Conversation: A Narrative Review of Cost-Informed Shared Decision Making and Its Impact on Medication Adherence in Chronic Conditions

    Dec 1, 2025, 00:00

  • EPH228 The Association Between Schizophrenia and Cardiovascular Diseases: A Retrospective Cohort Study in German Primary Care

    Dec 1, 2025, 00:00

  • SA73 Occurrence of Exacerbations and Mortality in High-Risk Chronic Obstructive Pulmonary Disease Patients While on Treatment With Dual or Triple Inhaled Therapy: Results From the SIRIUS Observational Study in the US

    Dec 1, 2025, 00:00

  • HTA334 The Uptake of R in NICE HTA: Insights From Technology Assessment Groups

    Dec 1, 2025, 00:00

  • RWD48 DARWIN EU® Characterizing Clinically Recognized Hypertrophic Cardiomyopathy in Six European Countries: A Descriptive Analysis Using Real-World Data

    Dec 1, 2025, 00:00

  • EE326 Development and Validation of a Novel Patient Microsimulation Cost-Effectiveness Model to Evaluate Automated Insulin Delivery Systems in Type 2 Diabetes

    Dec 1, 2025, 00:00

  • CO249 The Value of Persistence in Neovascular Age-Related Macular Degeneration

    Dec 1, 2025, 00:00

  • MSR32 Applying the Delphi Method: A Scoping Review in Healthcare Decision Making and HEOR

    Dec 1, 2025, 00:00

  • EE579 Micro-Costing Analysis of the Economic Burden of Metabolic Dysfunction-Associated Steatohepatitis and Its Comorbidities in Saudi Arabia

    Dec 1, 2025, 00:00

  • CO174 Overall Survival With Second-Generation Androgen-Receptor Signaling Inhibitors in Patients With Metastatic Castration Resistant Prostate Cancer: An Umbrella Review

    Dec 1, 2025, 00:00

  • PCR181 Patient Preferences in Gene Therapy Development for Arrhythmogenic Cardiomyopathy: The UR-HEART Qualitative Study

    Dec 1, 2025, 00:00

  • SA76 Pragmatic Advice to Improve Assessment Schedule of Preference-Based Measures of Health to Estimate Utilities in Clinical Trials

    Dec 1, 2025, 00:00

  • EE99 Budget Impact Analysis of Tenecteplase vs. Alteplase for Adults With Acute Ischemic Stroke (AIS) in Greece

    Dec 1, 2025, 00:00

  • HTA137 Evidence of Mapping Malpractice? A Review of Mapping Algorithm Usage in NICE Health Technology Appraisals

    Dec 1, 2025, 00:00

  • HTA196 Implementation and Outcomes of Managed Entry Agreements Across the Nordic Region

    Dec 1, 2025, 00:00

  • MSR221 What Is the Value of Large Language Models for Improving Extraction and Interpretation of Efficiency Data From French Commission Dévaluation Économique et de Santé Publique (CEESP): Decisions on Breast Cancer Medications?

    Dec 1, 2025, 00:00

  • HTA300 Simulating PICOs to Predict Evidence Requirement Implications of the EU Joint Clinical Assessment: Learnings From 24 Case Studies

    Dec 1, 2025, 00:00

  • EE662 Societal Burden of Specific Learning Disorders With Focus on Secondary Mental Health Problems in Japan

    Dec 1, 2025, 00:00

  • MSR67 Defining Patient-Centered Outcomes in CAR-T-cell Therapy: Is There a Need for a Patient-Informed CAR-T PROM?

    Dec 1, 2025, 00:00

  • MSR9 A Retrieval-Augmented Generation (RAG)-Based Framework to Automate Report Writing for Systematic Literature Reviews (SLRs) in Evidence Synthesis

    Dec 1, 2025, 00:00

  • EE369 Economic Consequences of Disease-Related Malnutrition in Poland and the Potential Cost Savings From Nutritional Interventions: A Two-Step Modeling Study

    Dec 1, 2025, 00:00

  • EPH184 Prediabetes Prevalence and Progression in the UAE: Insights for Early Intervention and Resource Optimization

    Dec 1, 2025, 00:00

  • EE58 Assessing the Budget Impact of Bimekizumab in the Management of Hidradenitis Suppurativa in France

    Dec 1, 2025, 00:00

  • HPR9 A Review of the UK's International Recognition Procedure and Its Role in Expediting Access to Innovative Treatments

    Dec 1, 2025, 00:00

  • PCR167 Outcome Measures Relevant for Assessing Health-Related Quality of Life and Utility in Primary Lateral Sclerosis (PLS)

    Dec 1, 2025, 00:00

  • PCR80 Evaluating Migration Errors in COA: Development and Validation of the IQVIA Migration Error Severity Scale (I-MESS)

    Dec 1, 2025, 00:00

  • HTA202 Insights and Implications an Analysis of the Studies Undertaken by HTAIn (Health Technology Assessment in India)

    Dec 1, 2025, 00:00

  • EE509 Healthcare Resource Utilization (HCRU) and Associated Costs in Patients With Advanced Merkel Cell Carcinoma (aMCC) in Germany: Analysis From the MCC TRIM Registry Study

    Dec 1, 2025, 00:00

  • HTA72 Challenges in Predicting the Joint Clinical Assessment (JCA) Scope From a Stakeholder Perspective: A Case Study in Relapsed/Refractory Multiple Myeloma

    Dec 1, 2025, 00:00

  • RWD142 Real-World Healthcare Resource Utilization and Costs Associated With Malignant Brain Tumors in the Brazilian Private Market

    Dec 1, 2025, 00:00

  • EE7 A Conceptual Paper on Integrating a Pharmacometric Multistate Model With Cost-Effectiveness Analysis for Infectious Diseases Treatment Optimization

    Dec 1, 2025, 00:00

  • PCR42 Characterizing the UK Population Living With Von Willebrand Disease: Foundational Data for Health Economics and Outcomes Research

    Dec 1, 2025, 00:00

  • RWD122 Medical Resource Utilizations and Economic Burden of Chemotherapy-Induced Anemia in Chinese Population: A Multicenter Retrospective Study

    Dec 1, 2025, 00:00

  • EE702 The Economic Burden of Overweight and Obesity in Europe: A Systematic Literature Review

    Dec 1, 2025, 00:00

  • EE277 Cost-Effectiveness of Strategies to Prevent Respiratory Syncytial Virus Infections Among Infants in Ireland

    Dec 1, 2025, 00:00

  • CO5 A Systematic Review and Network Meta Analysis of Pharmacologic Disease-Modifying Therapies for Early Alzheimer's Disease

    Dec 1, 2025, 00:00

  • CO95 Efficacy and Safety of Once-Weekly and Once-Daily Basal Insulins in Type 1 Diabetes Mellitus: A Systematic Review and Network Meta-Analysis of Clinical Trials

    Dec 1, 2025, 00:00

  • HSD29 CREST Physician Experience Survey: Evaluating the Impact of Time and Effort of Treatment Administration in Non-Muscle Invasive Bladder Cancer (NMIBC)

    Dec 1, 2025, 00:00

  • EPH144 Incidence of Tick-Borne Encephalitis in Germany Comparison of Claims Data With Public Surveillance Data

    Dec 1, 2025, 00:00

  • CO4 A Systematic Review (SR) and Network Meta-Analysis (NMA) of Cystic Fibrosis Transmembrane Conductance Receptor (CFTR) Modulator Therapies and Established Clinical Management (ECM) Using Percent Predicted Forced Expiratory Volume in One ...

    Dec 1, 2025, 00:00

  • HTA16 A Systematic Literature Review of the Mitigation Strategies to Overcome the Risk for Confounding of Overall Survival in Trials With Crossover/Treatment Switching Evaluated in Health Technology Assessments of Treatments for Select Tumo ...

    Dec 1, 2025, 00:00

  • HTA130 Evaluating Clinical Similarity: A Systematic Review of Methods Used Within National Institute for Health and Care Excellence (NICE) Cost-Comparison Evaluations (CCEs) When Relying on Statistically Nonsignificant Differences From Indi ...

    Dec 1, 2025, 00:00

  • EE290 Costs Associated With the Treatment of Surgical Site Infections in Solid Organ Transplant Recipients: A Scoping Review

    Dec 1, 2025, 00:00

  • EPH265 Tropical Virus in Fran Dengue Cases on the Rise

    Dec 1, 2025, 00:00

  • MSR36 Artificial Intelligence in Systematic Reviews: An Investigation Into the Impact of Eligible Studies Being Excluded by Artificial Intelligence

    Dec 1, 2025, 00:00

  • EE120 Can Intravitreal Aflibercept 8 mg Result in Decreased Treatment Burden and Treatment Costs in European Patients With Age-Related Macular Degeneration? Early Evidence From Clinical Practice

    Dec 1, 2025, 00:00

  • EE628 Quantifying the Fiscal Value of Prevention Programs for Depression

    Dec 1, 2025, 00:00

  • RWD102 Improving Identification of Patients With Rare Diseases Through Indirect Linkage Between French Medico-Administrative Claims Database (SNDS) and National Rare Disease Registry (BNDMR) in Fran A Dual-Population Study

    Dec 1, 2025, 00:00

  • EE288 Costs Associated With Kidney Transplant in Portugal

    Dec 1, 2025, 00:00

  • EE425 Estimating the Cost-Effectiveness of Tumor-Treating Fields With Gemcitabine and Nabpaclitaxel for Frontline Treatment of Locally Advanced Pancreatic Adenocarcinoma

    Dec 1, 2025, 00:00

  • PCR222 Strengths and Limitations of AI-Assisted Abstract Screening to Identify Patient-Reported Outcome Instruments: A Comparison of Two AI-Assisted Platforms and Traditional Methods

    Dec 1, 2025, 00:00

  • OP23 Streamlining Cancer Treatment Pathways: Organizational Responses to Rising Chemotherapy Volumes

    Dec 1, 2025, 00:00

  • EE81 Budget Impact Analysis of Dimethyl Fumarate for the Treatment of Relapsing/Remitting Multiple Sclerosis in Iraq

    Dec 1, 2025, 00:00

  • EE620 Projected Public Health Impact of Synchronized COVID-19 and Influenza Vaccination With a Combination Vaccine in US Older Adults

    Dec 1, 2025, 00:00

  • SA13 Approaches Used in Assessing the Environmental Sustainability of Digital Health Technologies: A Systematic Review

    Dec 1, 2025, 00:00

  • HTA124 Enhancing Patient Involvement in European Health Technology Assessment (HTA): From Inconsistent National Practices to Systematic Engagement in Joint Clinical Assessments

    Dec 1, 2025, 00:00

  • SA59 Laboratory Testing Patterns in Patients With Breast Cancer Treated With CDK4/6 Inhibitors: A Multi-Country Electronic Health Record Study From the UK, Germany, and Japan

    Dec 1, 2025, 00:00

  • EE420 Estimating Healthcare Resource Use Associated With the Treatment of Phenylketonuria in the United States

    Dec 1, 2025, 00:00

  • EPH190 Prevalence of Migraine in India: A Meta-Analysis Based on Diagnostic Criteria and Gender Differences

    Dec 1, 2025, 00:00

  • EE590 Modeling Treatment-Free Remission Outcomes for Asciminib in Newly Diagnosed Chronic Myeloid Leukemia: Assumptions, Methodology, and Projections

    Dec 1, 2025, 00:00

  • EE216 Cost-Effectiveness Analysis of Pharmacogenetic Testing to Guide Treatment for Children With Asthma

    Dec 1, 2025, 00:00

  • EE324 Developing the Next Generation of Therapeutics: The Role of Early Model-Based Cost-Effectiveness Analysis

    Dec 1, 2025, 00:00

  • PCR161 Mobility and Upper Extremity Function in Duchenne Muscular Dystrophy: A Longitudinal Survey Using PROMIS

    Dec 1, 2025, 00:00

  • MSR179 Reducing the Rare Disease Diagnostic Odyssey: Identifying Potential Pulmonary Arterial Hypertension Patients Using the Problem List of Diagnosed Patients

    Dec 1, 2025, 00:00

  • RWD28 Characteristics of Patients Treated With Biologic Agents for Moderate-to-Severe Atopic Dermatitis in Poland

    Dec 1, 2025, 00:00

  • EE47 An Economic Evaluation to Inform the Use of Enhanced Influenza Vaccines for Those Aged 65 Years and Older in the Seasonal Influenza Vaccination Program in Ireland

    Dec 1, 2025, 00:00

  • HPR37 Bridging the Gap: How Early Access Shapes Pricing and Reimbursed Populations in France

    Dec 1, 2025, 00:00

  • EE718 The Ongoing Challenge of Clostridioides Difficile Infection in Austria: Economic Evaluation of Two Recommended Treatment Pathways

    Dec 1, 2025, 00:00

  • Medicare Drug Price Negotiation Under the Inflation Reduction Act: Ensuring the Continuity of Critical Real-World Pharmaceutical Studies

    Dec 1, 2025, 00:00

  • RWD47 DARAH Project: Deploying a Datashield Federated Network in Real-World Healthcare Environments

    Dec 1, 2025, 00:00

  • EE753 What Is the Cost of Preventing Tuberculosis a Cost-Effectiveness Analysis of Household Contact Tracing With 3HP Preventive Therapy in High-Burden Areas of Nepal?

    Dec 1, 2025, 00:00

  • CO98 Epidemiological Study of Pulmonary Hypertension in Patients With Interstitial Lung Diseases (PH-ILD) in Gree A Retrospective Multicenter Study

    Dec 1, 2025, 00:00

  • P42 A Systematic Review of Economic Modeling Challenges and Proposed Solutions for Rare Disease Technologies: An HTAi RDIG Initiative

    Dec 1, 2025, 00:00

  • MSR28 Anchors Away: Navigating Unanchored Indirect Comparisons With Multilevel Unanchored Meta-Regression (ML-UMR)

    Dec 1, 2025, 00:00

  • HPR68 Eligibility and Strategic Implications of Germany’s 2025 Confidential Pricing Reform

    Dec 1, 2025, 00:00

  • RWD24 Association of Recurrences With Healthcare Resource Utilization in High-Risk Non-Muscle Invasive Bladder Cancer Patients Across Europe: A Real-World Survey

    Dec 1, 2025, 00:00

  • PCR55 Delayed Access to Diabetes Technology in Children With Migration Background: A Cross-Sectional Study on Treatment Equity in Austria

    Dec 1, 2025, 00:00

  • RWD26 Burden of Duchenne Muscular Dystrophy in Italy: A Multicenter Cost of Illness Study

    Dec 1, 2025, 00:00

  • EPH64 Disease Progression in Adults With Hepatitis Delta Virus vs. Hepatitis B Virus Monoinfection in Inpatient and Outpatient Settings in Italy

    Dec 1, 2025, 00:00

  • HPR125 Innovative Drug Access in Portugal: An Analysis of Managed Entry Agreements Supporting Public Coverage 2014-2024

    Dec 1, 2025, 00:00

  • EE546 Improved Outcomes and Cost Savings With the New-Generation Balloon-Expandable Covered Stent in Aortoiliac Occlusive Disease: Preliminary Results Overview From an Italian Perspective

    Dec 1, 2025, 00:00

  • HPR151 Optimizing Healthcare Systems in the MENA Region: Insights From Tailored Reimbursement for Innovative and Generic Essential Remedies (TRIGER) Meetings in Saudi Arabia and Algeria

    Dec 1, 2025, 00:00

  • EE752 What Are the Impacts of the Absence of Health Economic Evaluations for Drugs Granted an ASMR IV Rating by the French National Authority of Health (HAS)? An Analysis of Medicines Assessed Between May 2022 and May 2024

    Dec 1, 2025, 00:00

  • HTA9 A Matching-Adjusted Indirect Comparison (MAIC) of Rucaparib vs. Niraparib in the Maintenance Treatment of Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer (aOC) After Response to First-Line Platinum-Based Chemotherapy

    Dec 1, 2025, 00:00

  • RWD27 Challenges and Opportunities in Using Real-World Data for Healthcare in the Middle East and North Africa Region: A Systematic Scoping Review

    Dec 1, 2025, 00:00

  • CO165 Modeling Intelligence Quotient (IQ) Changes Relative to Blood Phe Levels in Individuals With Phenylketonuria (PKU) Treated With Sepiapterin and Sapropterin Dihydrochloride

    Dec 1, 2025, 00:00

  • MSR97 Evaluating the Use of Large Language Models (LLM) in Summarizing Treatment Guidelines: A Pilot Study

    Dec 1, 2025, 00:00

  • PCR141 Integrating PROMs Into Real-World Ophthalmology Practi A Pilot Project on Neovascular AMD

    Dec 1, 2025, 00:00

  • CO53 Comparative Effectiveness of Alectinib vs. Crizotinib as First-Line Therapy in ALK-Positive Non-Small Cell Lung Cancer: A Real-World Quasi-Experimental Study

    Dec 1, 2025, 00:00

  • EE155 Cost Analysis of Polatuzumab Vedotin in Combination With Rituximab Cyclophosphamide Doxorubicin and Prednisone in the Treatment of Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma in Portugal

    Dec 1, 2025, 00:00

  • CO50 Clinical Profile of Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Treated With Complement Inhibitors: Results From a Real-World Study

    Dec 1, 2025, 00:00

  • CO159 Lipid-Lowering Prescription Patterns After a Nonfatal Acute Coronary Syndrome: The Impact of Real-World Evidence on Clinical Practice With LATINO-ACS 2.0

    Dec 1, 2025, 00:00

  • RWD96 Health-Related Quality of Life in Adults With Dry Eye Disease in Fran Insights From a Multicenter Observational Study

    Dec 1, 2025, 00:00

  • EE407 EIGER: Cost Impact of Progression to Metastatic Disease Amongst US Patients With Gastric and Gastroesophageal Junction Cancer (GCGEJC)

    Dec 1, 2025, 00:00

  • EE331 Direct and Indirect Economic Burden Due to Chronic Limb-Threatening Ischemia (CLTI) in Germany

    Dec 1, 2025, 00:00

  • EE221 Cost-Effectiveness Analysis of the Prostate Health Index (PHI) Test After a Prostate-Specific Antigen (PSA) Test in UK

    Dec 1, 2025, 00:00

  • HSD31 Definitive Staging and Perioperative Treatment for Resectable Stage IB-IIIA Non-Small Cell Lung Cancer (NSCLC): A UK Perspective

    Dec 1, 2025, 00:00

  • EPH137 Impact of the Decline in the Number of Community Dermatologists in France on Treatment of Actinic Keratosis (EPIKA Study)

    Dec 1, 2025, 00:00

  • EE719 The Overlooked Need for Modeling Beyond Reimbursement to Support Therapy Uptake: Case Study of Botulinum Toxin for Spasticity Treatment

    Dec 1, 2025, 00:00

  • HPR170 Real-World Data for External Controls: Insights From EMA Regulatory Submissions

    Dec 1, 2025, 00:00

  • EE142 Comparing the Economic Burden in Patients With vs. Without Ehlers-Danlos Syndrome (EDS) Using a Large US Electronic Health Records Database

    Dec 1, 2025, 00:00

  • PCR119 Health-Related Quality of Life in Patients With Mild Cognitive Impairment and Dementia and Their Caregivers in Thailand: A Cross-Sectional Study

    Dec 1, 2025, 00:00

  • HPR6 A Cross-Sectional Analysis of the Reimbursement Obligation for CAR-T Drugs by Huiminbao Insurances in Mainland China of 2024

    Dec 1, 2025, 00:00

  • CO194 Public Health Impact of Bivalent Respiratory Syncytial Virus Prefusion F Vaccine for Prevention of Respiratory Syncytial Virus Illness Among High-Risk Adults Aged 18-59 Years in Germany

    Dec 1, 2025, 00:00

  • HTA156 From Pilot to Platform: Expanding Generative AI Coauthoring Across Global Value Dossier (GVD) Sections With Proven Quality and Validation

    Dec 1, 2025, 00:00

  • HTA46 Assessing the Value of the Enzyme Replacement Therapy for Hypophosphatasia (HPP): A Spanish Subanalysis of a Pan-European Multidisciplinary Multicriteria Decision Analysis (MCDA)

    Dec 1, 2025, 00:00

  • HTA244 Navigating HTA Requirements: The Current Landscape of Alzheimer's Disease-Modifying Treatments

    Dec 1, 2025, 00:00

  • HSD23 Characteristics of DNAR Orders Among Non-Critically Ill Extremely Elderly Patients Admitted to a University Hospital in Japan

    Dec 1, 2025, 00:00

  • HTA15 A Review of Utility Data Used in Health Technology Assessments From the Perspective of a Health Technology Assessment Body

    Dec 1, 2025, 00:00

  • EE174 Cost Implications of Declining MMR Coverage in England: Modeling NHS Burden and the Value of Catch-Up Vaccination

    Dec 1, 2025, 00:00

  • EE539 Impact of Nonclinically Driven Inhaler Initiation or Switch on Carbon (CO2) Emissions and Healthcare Costs for COPD Patients Using Single-Inhaler Triple Therapy (SITT)

    Dec 1, 2025, 00:00

  • CO140 Impact of Pharmacotherapy Adherence on the Reduction of Major Adverse Cardiovascular Events (MACE) Among Atherosclerotic Cardiovascular Disease (ASCVD) Patients

    Dec 1, 2025, 00:00

  • EE20 A Method to Estimate Causally Related Cost Savings of a Preventive Intervention: An Analysis Using the Wellness-Star∗ Database

    Dec 1, 2025, 00:00

  • HTA225 LLM Engineering in HEOR: Approaches to Improving Accuracy in Clinical Data Extraction

    Dec 1, 2025, 00:00

  • PCR114 Health-Related Quality of Life Following Administration of Influenza and COVID-19 Combination Vaccine in Older Adults: Results From a Phase 3 Randomized Controlled Trial

    Dec 1, 2025, 00:00

  • EPH197 Public Health and Economic Impact of RSVpreF Vaccination Among Older Adults in Latin America and the Caribbean

    Dec 1, 2025, 00:00

  • PCR124 Identification of Clusters of Patients With Similar Baseline Characteristics in the FOCAL-MS2 Study Evaluating Patient’s Autonomy

    Dec 1, 2025, 00:00

  • EE751 What Are the Biggest Value Drivers? A Comparison of the Relative Impacts of Six Novel Value Elements on Value Estimates Across Twelve Treatments Through Generalized Cost-Effectiveness Analyses

    Dec 1, 2025, 00:00

  • EPH22 Assessment Of Parental Knowledge Information-Seeking and Information-Providing Regarding Newborn And Infant Screening Examinations

    Dec 1, 2025, 00:00

  • CO128 Health Technology Assessment, Reimbursement, and Funding Landscape Challenges for Oncology Companion Diagnostics in Europe and Canada

    Dec 1, 2025, 00:00

  • EE218 Cost-Effectiveness Analysis of RefluxStop for Treatment of Chronic Gastro-esophageal Reflux Disease: A US Medicare Perspective

    Dec 1, 2025, 00:00

  • HSD18 Burden of In-Clinic and At-Home Administration of Injectable Biologics for Severe Asthma and Chronic Rhinosinusitis With Nasal Polyps: Interim Results From a Time and Motion Study

    Dec 1, 2025, 00:00

  • SA8 AI for Rapid Data Extraction: A Case Study on the Economic and Caregiver Burden of Motor Neuron Disease

    Dec 1, 2025, 00:00

  • EPH69 Effectiveness of HPV Vaccination Across Europe: A Comparative Analysis

    Dec 1, 2025, 00:00

  • PCR38 Care Partner Burden and Experiences With Schizophrenia: A National Canadian Survey

    Dec 1, 2025, 00:00

  • HSD75 Modeling the Anticipated Organizational Impact on Health Service Provision of the Introduction of Tirbanibulin for the Topical Treatment of Actinic Keratosis in Fran EPIKA Study

    Dec 1, 2025, 00:00

  • MSR76 Diagnostic Patterns and Subtype Overlap in Idiopathic Inflammatory Myopathies: A Retrospective Claims-Based Cohort Study

    Dec 1, 2025, 00:00

  • EE412 Enhancing Palliative Care in Intensive Care Units (EPIC) Trial Design of the Health Economic Substudy

    Dec 1, 2025, 00:00

  • HSD2 A Comprehensive Approach Including Mailed FITs and Nurse Navigation for Colorectal Cancer Screening

    Dec 1, 2025, 00:00

  • HTA175 Health Technology Assessment of Emicizumab for Pediatric Hemophilia A From a Hospital Perspective

    Dec 1, 2025, 00:00

  • HPR124 Innovation on Hold: A 2020-2025 Analysis of the Conditional Drug Reimbursement Framework

    Dec 1, 2025, 00:00

  • EE122 CAR-NK Cell Therapy for Ovarian Cancer Treatment in the First Relapse: Assessing Conditions Needed for Cost-Effectiveness in the Netherlands Using Early Health-Economic Modeling

    Dec 1, 2025, 00:00

  • HPR230 Unlocking Access: Overcoming Barriers and Harnessing Enablers for Innovative Payment Models for Pharmaceutical Innovation in Europe

    Dec 1, 2025, 00:00

  • PCR214 Sex Differences in Chronic Hand Eczema (CHE) Triggering Factors: Comorbidities, Lifestyle, and Exposures Findings From a Multinational Study in Six Countries

    Dec 1, 2025, 00:00

  • HSD68 Lean Assessment Process Methodology for RMD-Health: Evaluating Clinical Need Usefulness Adoption Barriers and Early Economic Value of AI in NHS Rheumatology Referrals

    Dec 1, 2025, 00:00

  • EPH172 Objective Real-World Caregiver Costs and Lost Time for Absences and Family Medical Leaves in the United States for Employees Whose Spouses Have Dementia and/or Alzheimer’s Disease and Patient Direct Costs

    Dec 1, 2025, 00:00

  • SA29 Design, Implementation, Data Analysis on the Time-Motions Studies: A Targeted Literature Review

    Dec 1, 2025, 00:00

  • EE325 Development and Application of a JCA-Alignment Checklist for Early Economic Modeling in EU HTA

    Dec 1, 2025, 00:00

  • HPR117 Impact of the COVID-19 Pandemic on Healthcare Expenditure

    Dec 1, 2025, 00:00

  • HPR134 Maintaining Orphan Drug Status at the Time of Drug Approval in European Economic Area (EEA): European Union (EU) Plus Iceland and Norway From 2015 to 2025

    Dec 1, 2025, 00:00

  • HTA138 Evidence Strategy Starts Early: Integrating HTA Needs Through PICO Simulation in Metastatic Castration-Resistant Prostate Cancer

    Dec 1, 2025, 00:00

  • EE29 A Real-World Study of Healthcare Resource Utilization (HCRU) and Associated Healthcare Costs for Patients With Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC) in Taiwan

    Dec 1, 2025, 00:00

  • SA16 Beyond Leave-One-Out: A Ranked Leave-k-Out Method for Detecting Influential Studies

    Dec 1, 2025, 00:00

  • HPR194 The Clawbacks Paradox: When Abusing a Simple Approach Has the Most Complicated and Problematic Consequences for Patients and Healthcare Systems

    Dec 1, 2025, 00:00

  • MT37 Robotic Surgery: A Budget Analysis in the Italian Healthcare Setting

    Dec 1, 2025, 00:00

  • EE365 Economic Burden of Schizophrenia: A Systematic Literature Review

    Dec 1, 2025, 00:00

  • PCR260 Utility Estimates for Health States Associated With Immune Thrombocytopenia: A Systematic Literature Review

    Dec 1, 2025, 00:00

  • P5 The Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH) in the US: A Total System Value Evidence Framework

    Dec 1, 2025, 00:00

  • EE366 Economic Burden of Systemic Lupus Erythematosus (SLE) Among Women in the USA: A Systematic Review

    Dec 1, 2025, 00:00

  • EE299 Cost-Utility Analysis of AI-Assisted Ultrasound for Breast Cancer Detection in Taiwan

    Dec 1, 2025, 00:00

  • SA9 AI in Pragmatic Literature Reviews: A Scoping Review of Current Guidance and Development of a Framework for Integration

    Dec 1, 2025, 00:00

  • EE308 Cost-Utility Analysis of Standard-Dose vs. High-Dose Influenza Vaccination in Adults Aged ≥ 65 Years in Italy

    Dec 1, 2025, 00:00

  • EPH106 Exploring the Broader Value of Adult Respiratory Vaccination Programs in Gree A Public Health Perspective

    Dec 1, 2025, 00:00

  • RWD101 Improving Data Quality in Oncology Electronic Health Record (EHR)-Derived Databases for Research and Regulatory Decision Making

    Dec 1, 2025, 00:00

  • EPH271 Unmet Needs in Late-Line Metastatic Colorectal Cancer in Portugal: An Expert-Informed Epidemiological Forecast

    Dec 1, 2025, 00:00

  • EE734 Treatment Failure Event Categories Reveal Progressive Increases in Disease and Economic Burden Among Patients With Major Depressive Disorder

    Dec 1, 2025, 00:00

  • MSR73 Development of Cardiovascular Risk Equations: Integrating Clinical Expertise With Data From the SELECT Trial

    Dec 1, 2025, 00:00

  • PCR90 Exploring Beyond the Gut: A Qualitative Study of Extraintestinal Symptoms in Ulcerative Colitis and Crohn's Disease

    Dec 1, 2025, 00:00

  • EE372 Economic Evaluation of a Booster Dose of TDaP Vaccine to Adolescents in Spain

    Dec 1, 2025, 00:00

  • HPR196 The Development of the Private Healthcare Sector in Romania Between 2005 and 2023

    Dec 1, 2025, 00:00

  • SA52 Impact of Different Thresholds of Increasing or Decreasing Body Mass Index on Noncommunicable Diseases Through a Discrete Event Simulation Model

    Dec 1, 2025, 00:00

  • CO10 Analysis of Pooled Real-World Utilization and Outcomes Data of rVIII-Single Chain Compared With Standard and Extended Half-Life FVIII Products for Prophylaxis of Hemophilia A in France, Germany, and Italy

    Dec 1, 2025, 00:00

  • CO133 Identifying Dogs to Be Screened for Canine Chronic Kidney Disease (cCKD)

    Dec 1, 2025, 00:00

  • EE465 Financial and Mental Health Burden on Caregivers of Patients With Neuromyelitis Optica Spectrum Disorder (NMOSD) in the United States

    Dec 1, 2025, 00:00

  • EPH261 Trends in Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Prescribing in England: A Data Analysis Using NHS Prescription Episodes Statistics (PES)

    Dec 1, 2025, 00:00

  • HPR127 International Reference Pricing (IRP) Analysis for Generic Medicines in Türkiye in 2024

    Dec 1, 2025, 00:00

  • RWD75 Epidemiology of Pulmonary Arterial Hypertension In Fran A Real-World Study Using the French National Healthcare Database (SNDS)

    Dec 1, 2025, 00:00

  • EE145 Comparison of Time-Driven Activity-Based Costs Incurred by Patients and Caregivers Related to Intravitreal Injections for Retinal Vein Occlusion

    Dec 1, 2025, 00:00

  • EE570 Malnutrition-Related Healthcare Costs in Hospitalized IBD Patients: A Nationwide Real-World Data Analysis in Italy

    Dec 1, 2025, 00:00

  • EE581 Mobile Diagnostic Services for Stationary Care in Germany: An Economic Evaluation Model for the DIKOM Project (01NVF21101)

    Dec 1, 2025, 00:00

  • MT25 Hope and Acceptance of AI-Guided Psychotherapy: Patient Adoption of Conversational AI in Mental Health Care

    Dec 1, 2025, 00:00

  • EE60 Assessing the Cost-Effectiveness of Subcutaneous Semaglutide 2.4 mg in the Management of Individuals With Obesity and Prediabetes in England

    Dec 1, 2025, 00:00

  • P64 Patient Engagement in Economic Evaluations of Cancer Care: Mapping the Landscape and Advancing Practice

    Dec 1, 2025, 00:00

  • CO118 Exploring Synergistic ADC-ICI Combinations in Breast Cancer: Clinical Insights From a Scoping Review

    Dec 1, 2025, 00:00

  • PCR219 Socioeconomic Burden of Pulmonary Arterial Hypertension on Patients and Caregivers in the Czech Republic

    Dec 1, 2025, 00:00

  • CO69 Delphi Panel for Standardizing Outcome Measures in Radical Prostatectomy Surgical Care Pathway

    Dec 1, 2025, 00:00

  • MT26 HTA Requirements for Medical Technologies in Germany

    Dec 1, 2025, 00:00

  • RWD97 Hidden Obesity and Treatment Gaps in Japan: A Real-World Data Analysis

    Dec 1, 2025, 00:00

  • EPH155 KRAS Alterations in Advanced Non-Small Cell Lung Cancer (NSCLC): Temporal Trends in Testing Patterns and Targeted Treatment Use Across Europe Between 2018 and 2024

    Dec 1, 2025, 00:00

  • EE524 Humanistic and Economic Burden of Primary Biliary Cholangitis: A Systematic Review of Health-Related Quality of Life Healthcare Resource Utilization and Associated Cost

    Dec 1, 2025, 00:00

  • SA77 Premium Relief Through Prevention: Actuarial Valuation of Herpes Zoster Vaccination

    Dec 1, 2025, 00:00

  • MSR213 Use of Multilevel Network Meta Regression (ML-NMR) Model in RET Mutation-Positive Medullary Thyroid Cancer (MTC)

    Dec 1, 2025, 00:00

  • EE284 Cost-per-Remission of Vedolizumab vs. Risankizumab for the Treatment of Moderate-to-Severely Active Crohn’s Disease in Italy, France, and Canada

    Dec 1, 2025, 00:00

  • EPH7 A Real-World Survey of Health Inequalities as Drivers for Burden on Male Hemophilia Patients in the US, EU5, and Asia

    Dec 1, 2025, 00:00

  • CO129 Healthcare Resource Utilization and Disease Progression in Patients With Primary Hyperoxaluria: A Retrospective Cohort Study

    Dec 1, 2025, 00:00

  • EE374 Economic Evaluation of Atogepant vs. Placebo for the Preventive Treatment of Episodic Migraine in Taiwan

    Dec 1, 2025, 00:00

  • HSD34 Digital Divide in Health Information Seeking: Rural and Urban Differences in the Use of Online Health Tools in the United States

    Dec 1, 2025, 00:00

  • PCR54 Cross-Country Comparison of Cancer-Related Health Preferences Using the EORTC QLU C10D: Evidence Supporting Standardized Value Sets

    Dec 1, 2025, 00:00

  • EE87 Budget Impact Analysis of Hyaluronic Acid Viscosupplementation for Knee Osteoarthritis in Colombia

    Dec 1, 2025, 00:00

  • SA62 Leveraging Real-World Data to Conduct Noninterventional Studies in Rare Disease Populations: Lessons in Scalability and Data Access From Three Observational Studies

    Dec 1, 2025, 00:00

  • HTA245 Navigating Joint Clinical Assessment in Europe: Strategic Roadmap and Recommendations for Health Technology Developers

    Dec 1, 2025, 00:00

  • EE80 Budget Impact Analysis of 68-Ga-PSMA-11 PET CT Imaging Followed by 177Lu-PSMA-617 Therapy in Metastatic Castrate-Resistant Prostate Cancer

    Dec 1, 2025, 00:00

  • MSR157 Optimized Piecewise Exponential Modeling Using Dynamic Programming: An Illustration From Treatment-Naïve Advanced Melanoma

    Dec 1, 2025, 00:00

  • HSD66 Is There Sufficient Economic Evidence for Reimbursing Behavioral Interventions? A Targeted Literature Review

    Dec 1, 2025, 00:00

  • EE144 Comparison of the Environmental Impact of Subcutaneous vs. Oral Therapies

    Dec 1, 2025, 00:00

  • HTA35 Applicability of the STEDI Value Framework to Vaccines in Health Technology Assessment: Opportunities and Considerations

    Dec 1, 2025, 00:00

  • PCR117 Health-Related Quality of Life in Patients Living With Osteosarcoma in Europe: A Systematic Review

    Dec 1, 2025, 00:00

  • RWD58 Detection of a Novel Safety Signal for Atorvastatin Potential Association With Hilar Lymphadenopathy Using FAERS Disproportionality Analysis and Molecular Docking

    Dec 1, 2025, 00:00

  • PCR14 Advancing Patient-Centered Value Assessment in Inherited Retinal Diseases: Leveraging EQ-5D-5L Vision Bolt-ons to Support IRD-Specific PROMs

    Dec 1, 2025, 00:00

  • CO141 Impact of Prenatal Exposure to Antidepressants on Adverse Birth and Pregnancy Outcomes: A Propensity-Scored Matched Retrospective Cohort Study Using a Large Electronic Medical Record Database 2012-2021

    Dec 1, 2025, 00:00

  • EE660 Societal and Economic Impact of NOAC Therapy for Deep Vein Thrombosis and Pulmonary Embolism in Bulgaria

    Dec 1, 2025, 00:00

  • SA106 Work Productivity Loss Among Caregivers of Pediatric Patients With COVID-19 OR Influenza/Influenza-Like Illness: A Systematic Literature Review

    Dec 1, 2025, 00:00

  • MT34 Patient Acceptance of Health Information Technologies: Comparative Insights From Wearables, TelE-Medicine, and mHealth

    Dec 1, 2025, 00:00

  • PT34 A Transitional Reimbursement Mechanism for New Medicinal Products Addressing High Unmet Clinical Need in Gree Proposal for a Medicines Innovation Fund

    Dec 1, 2025, 00:00

  • HTA348 US PIE and AMCP Dossiers: Payer Preferences Best Practice and a Comparison With Global Evidence Dossiers

    Dec 1, 2025, 00:00

  • EE441 Evaluating the Economic Burden of Polycythemia Vera Across the Disease Continuum: A Systematic Literature Review

    Dec 1, 2025, 00:00

  • HTA89 CONITEC in Action: A Trend Analysis of CONITEC’s Evaluation Outcomes From 2020 to Present Day

    Dec 1, 2025, 00:00

  • EPH104 Exploring Factors Associated With Online Food Delivery Behavior Among Young Adults

    Dec 1, 2025, 00:00

  • PCR250 Treatment Preferences in Adults With Chronic Spontaneous Urticaria Symptomatic on H1-Antihistamines in China: Insights From CHOICE-CSU 2 Study

    Dec 1, 2025, 00:00

  • CO37 Cardiovascular Effects of Semaglutide in Patients With Obesity, With or Without Type 2 Diabetes (T2DM): An Umbrella Review

    Dec 1, 2025, 00:00

  • EE646 Regulatory Approval and Economic Evaluation of Tumor-Agnostic Therapies: A Comparative Study of Larotrectinib and Entrectinib

    Dec 1, 2025, 00:00

  • OP20 Qualitative Insights Into Artificial Intelligence (AI) and Virtual Reality (VR) Training for Value Communication: Comparing Innovative Technologies With Traditional Methods in Pharma

    Dec 1, 2025, 00:00

  • EE698 The Economic Burden of Acromegaly Disease in the Kingdom of Saudi Arabia

    Dec 1, 2025, 00:00

  • Award Winners

    Dec 1, 2025, 00:00

  • HSD80 Organizational Support in Adopting New Treatments for Generalized Myasthenia Gravis

    Dec 1, 2025, 00:00

  • HTA85 Competing Beyond the First Mover: How Late to Market Analogues Navigate Pricing and Access in Major Global Markets

    Dec 1, 2025, 00:00

  • EE629 Quantifying the Impact of Inconsistencies in Economic Modeling Assumptions: A Case Study in Metastatic Colorectal Cancer

    Dec 1, 2025, 00:00

  • EE596 Operational and Economic Impact of CLL Treatment Regimens: Insights From a Multidisciplinary Study in Portugal

    Dec 1, 2025, 00:00

  • HPR62 Do Patient-Reported Outcomes Influence Drug Prices? Evidence From the Italian Pricing and Reimbursement System

    Dec 1, 2025, 00:00

  • HPR175 Resilient Pharmaceutical Supply Chains in Times of Crisis: A Comparative Analysis of Australia, France, Italy, Spain, and UK

    Dec 1, 2025, 00:00

  • RWD110 Integrating Prospective and Retrospective Real-World Data to Construct External Comparator Arms: Novel Methods and Design Considerations

    Dec 1, 2025, 00:00

  • HTA324 The Next Frontier in HTA Reviewing the Integration of Artificial Intelligence and Discrete Event Simulation for Resource Modeling

    Dec 1, 2025, 00:00

  • PCR50 Comparison of Clinical Outcome Assessment in Randomized Controlled Trials and in Observational Studies for Amyotrophic Lateral Sclerosis: A Scoping Review

    Dec 1, 2025, 00:00

  • EPH120 Healthcare Pathway of a Large Cohort of Patients With Chronic Obstructive Pulmonary Disease During the Last Year of Life

    Dec 1, 2025, 00:00

  • HTA342 Trends and Tensions in NICE Severity Modifiers: Analyzing the Acceptance and Critique of Manufacturer Severity Modifier Proposals in Recent Appraisals

    Dec 1, 2025, 00:00

  • PCR25 Assessment of Dermatology Life Quality Index Relevant (DLQI-R) in Psoriasis: A Practical Tool for Measuring Quality of Life in Elderly Populations

    Dec 1, 2025, 00:00

  • EE186 Cost per Responder of TAR-200 vs. Other FDA-Approved Novel and Generic Treatments Among Bacillus Calmette-Guérin-Unresponsive High-Risk Non-Muscle Invasive Bladder Cancer With Carcinoma in Situ in the United States

    Dec 1, 2025, 00:00

  • MSR162 PACE in Scotland: Utilizing Machine Learning to Assess the Importance of Patient and Clinician Engagement in HTAs in SMC

    Dec 1, 2025, 00:00

  • MSR151 Modeling the Future Clinical and Environmental Burden of Chronic Kidney Disease in Ghana and Uganda Between 2025 and 2030

    Dec 1, 2025, 00:00

  • HSD71 Mapping the Burden of Seizure Emergencies in Spain: A Systematic Literature Review

    Dec 1, 2025, 00:00

  • HTA182 How Will Patient Registry Data Play a Role in Joint Clinical Assessment (JCA) for Rare Diseases Learnings From National Health Technology Assessments (HTAs)?

    Dec 1, 2025, 00:00

  • MSR219 Variations in Mortality Across Clinical Trials: A Review of Statistical Methods for Adjusting for the Effect of the COVID-19 Pandemic

    Dec 1, 2025, 00:00

  • CO253 Transfusion Healthcare Resource Utilization and Associated Impact of Quality of Life Among Patients With Myelofibrosis and Anemia: A Multinational Real-World Survey

    Dec 1, 2025, 00:00

  • HSD21 Care Pathways Before and After Initial Diagnosis and Geographical Disparities Among Patients With Obstructive Hypertrophic Cardiomyopathy in Fran A Retrospective Claims Analysis

    Dec 1, 2025, 00:00

  • EE532 Impact of Higher-Valent Pediatric Pneumococcal Vaccines on Antimicrobial Resistant Infections and Antibiotic Prescriptions in Greece

    Dec 1, 2025, 00:00

  • EPH176 Persistence With Antidementia Therapy in Germany: A Retrospective Cohort Study of 212,850 Patients

    Dec 1, 2025, 00:00

  • EPH5 A Real-World Study on Hospital and Economic Burden of Dengue Fever in French Overseas Territories

    Dec 1, 2025, 00:00

  • HSD24 Clinical Characteristics Among Patients Screening for Hepatitis C Virus (HCV) and HCV Positivity Rates, 2020-2024: Analysis of US Real-World Data

    Dec 1, 2025, 00:00

  • HPR92 Factors Impacting GKV Rebates for Orphan Drugs (OD) in Germany: A Decision Analysis Using the CRA RADAR Database

    Dec 1, 2025, 00:00

  • EE531 Impact Of Dupilumab Treatment on Work-Related Medical Leave In Patients With Atopic Dermatitis in a Colombian Health Insurance Provider: An Observational Real-World Practice Study

    Dec 1, 2025, 00:00

  • PCR198 Psychometric Validation Of The North Star Assessment For Limb-Girdle Type Muscular Dystrophies (NSAD) In Limb-Girdle Muscular Dystrophy Sarcoglycanopathies (LGMD 2C/2D/2E) Using Baseline JOURNEY Data

    Dec 1, 2025, 00:00

  • EE281 Costing Analysis for the Management of Localized Renal Cell Carcinoma From the UK NHS Perspective

    Dec 1, 2025, 00:00

  • EE295 Cost-Utility Analysis (CUA) of Sepiapterin for Treatment of Phenylketonuria (PKU)

    Dec 1, 2025, 00:00

  • EE335 Disability-Associated Economic Burden Among Patients With Wilson’s Disease in South Korea: A Nationwide Cost-of-Illness Study

    Dec 1, 2025, 00:00

  • RWD163 Real-World Study of Breast Cancer Epidemiology and Treatment Patterns: A Pilot Study to Assess EHR-Derived Data in the United Kingdom

    Dec 1, 2025, 00:00

  • HPR52 Current Status of Home-Healthcare Pilot Programs in South Korea and Policy Discussions for Institutionalization

    Dec 1, 2025, 00:00

  • EE181 Cost of Illness Study: Cushing's Syndrome in the Kingdom of Saudi Arabia

    Dec 1, 2025, 00:00

  • MSR155 New Developments in the Psychometric Testing of the Patient-Reported Impact of Dermatological Diseases (PRIDD) Questionnaire: Responsiveness and Minimally Important Change

    Dec 1, 2025, 00:00

  • EE261 Cost-Effectiveness of Mixed-Approach Maternal RSVpreF/Infant Nirsevimab Immunization vs. Nirsevimab Alone for Prevention of Respiratory Syncytial Virus in Spain

    Dec 1, 2025, 00:00

  • EPH262 Trends in Hospital Treatment of Follicular Lymphoma in Germany

    Dec 1, 2025, 00:00

  • HTA335 The Use of Real-World Evidence in Health Technology Assessment and the Application of the NICE RWE Framework: A Review of NICE Technology Appraisals

    Dec 1, 2025, 00:00

  • MSR92 Evaluating the Conceptual Structure of the Barriers to Preexposure Prophylaxis (PrEP) Access Survey: A Confirmatory Item Factor Analysis

    Dec 1, 2025, 00:00

  • EE672 Stop Ignoring Missing Patients the Hidden Impact of Ignoring Missing Data in Health State Utility Estimation

    Dec 1, 2025, 00:00

  • HTA370 Why Current HTA Frameworks Fall Short for Anti-Cancer Combination Therapies: Toward Equitable Value Attribution and Policy Reform

    Dec 1, 2025, 00:00

  • EPH77 Epidemiological Trends in HPV-Related Cancers and Diseases in the United Kingdom

    Dec 1, 2025, 00:00

  • MT22 Global Evaluation of Flexible Cysto-Nephroscope Usage Patterns in Percutaneous Nephrolithotomy Procedures

    Dec 1, 2025, 00:00

  • SA56 Integrating Stakeholder Insights Into Thematic Analysis: Enhancing Efficiency and Supporting HEOR

    Dec 1, 2025, 00:00

  • EPH178 Pertussis Vaccination and Test Rates in Germany by Asthma-COPD Comorbidity Status: A Healthcare Claims Data Analysis in Germany

    Dec 1, 2025, 00:00

  • HTA232 Methodological Insights From Recent PBAC Recommendations to Support Biosimilar Reimbursement in Australia

    Dec 1, 2025, 00:00

  • OP19 Qualitative Evaluation of an AI Tool for Opportunistic Detection of Vertebral Fractures in the National Health Service

    Dec 1, 2025, 00:00

  • HPR146 Navigating the Influence of Traditional Chinese Medicine (TCM) on the Positioning of New Treatments in China: A Review of TCM Inclusion in Clinical Guidelines

    Dec 1, 2025, 00:00

  • CO109 Evaluating the Lifetime Incremental Value of Pharmaceutical Innovation: The Case of Non-Small Cell Lung Cancer

    Dec 1, 2025, 00:00

  • EE729 The Working Dead? Why Longer Lives Can Seem Less Productive

    Dec 1, 2025, 00:00

  • HTA83 Comparing Risk of Bias Assessment Requirements Between the EU JCA and European HTA Agencies

    Dec 1, 2025, 00:00

  • EE422 Estimating Quality-Adjusted Life Expectancy by Ethnicity for Application in Distributional Cost-Effectiveness Analysis

    Dec 1, 2025, 00:00

  • EE238 Cost-Effectiveness of CKD Screening: Insights for the 60+ General Population and Those With Type 2 Diabetes

    Dec 1, 2025, 00:00

  • HTA163 Germany: Still a Benchmark for ATMP Access and Pricing: A Pricing Analysis of Germany's ATMP Landscape Compared to Other European Countries

    Dec 1, 2025, 00:00

  • EPH136 Impact of RSV Infection on Acute Otitis Media Burden in Young Children Beyond Their First Year of Life in Japan

    Dec 1, 2025, 00:00

  • PT29 From Code to Quality: Identifying Quality Assurance Steps for AI Integration in Qualitative Healthcare Research: A Comparative Study of ChatGPT, Atlas.ti, and Traditional Coding

    Dec 1, 2025, 00:00

  • CO15 Assessing the Clinical Impact of Decreasing Weight in Young Adults Using the Metabo-Reno-Cardiovascular Disease Model©

    Dec 1, 2025, 00:00

  • HPR165 Price-Volume Regulation in Fran Alignment Between Negotiated Thresholds With the French Economic Committee for Health Products (CEPS) and Real-World Observations

    Dec 1, 2025, 00:00

  • EPH118 (HCRU)/Costs and Epidemiology of Patients With ADHD in Germany: A Claims Data Study (HEDDA)

    Dec 1, 2025, 00:00

  • MT7 Assessing the Economic Impact of a Robotic-Assisted Solution vs. a Manual Approach in Total Knee Arthroplasty in the UK

    Dec 1, 2025, 00:00

  • Testing the Valuation of the EQ-5D-Y-5L in Adults and Adolescents: Results From a 5-Country Study and Implications for the Descriptive System

    Dec 1, 2025, 00:00

  • CO1 A Balancing Act: Low-Dose Atropine Significantly Slows Pediatric Myopia Progression Without a Clinically Meaningful Risk of Rebound (Accelerated Myopia Progression Following Treatment Cessation)

    Dec 1, 2025, 00:00

  • EE522 HPV-Related Disease Burden in Men and Women in the Czech Republic: A Claims Database Analysis

    Dec 1, 2025, 00:00

  • PCR150 Looking Back to Go Forward: Reintegrating Scientific Considerations Into eCOA Design and Implementation

    Dec 1, 2025, 00:00

  • HSD48 Evaluation of the Article 51 VIGIE-AGE Experiment: A Significant Impact on Hospitalizations Resulting in Reduced Total Expenditure

    Dec 1, 2025, 00:00

  • EE248 Cost-Effectiveness of Epigenetic Drugs in Oncology: A Systematic Review of Economic Evaluations

    Dec 1, 2025, 00:00

  • SA51 Impact of CIDP on Health-Related Quality of Life Fatigue and Daily Activities: Results From a Real-World International Survey

    Dec 1, 2025, 00:00

  • MT46 Value of in Vitro Diagnostic IVD Tests in Health Society and Economy in Portugal

    Dec 1, 2025, 00:00

  • HPR182 Shifts in Medicine Reimbursement in Türkiye: Who Pays for Medicines (2015-2022)?

    Dec 1, 2025, 00:00

  • PCR211 Review of Patient Decision Aids for Psoriasis

    Dec 1, 2025, 00:00

  • OP15 Market Access AI Readiness: Maximizing Strategic Alignment Through Organizational Insights

    Dec 1, 2025, 00:00

  • EE169 Cost-Effectiveness of Nemolizumab in the Treatment of Patients With Moderate-to-Severe Prurigo Nodularis in Italy

    Dec 1, 2025, 00:00

  • HTA338 Tracing the Shift in Payer Evidence Expectations: A Review of AMCP Format Updates (2016-2024)

    Dec 1, 2025, 00:00

  • CO172 Nutritional Profile and Cost Evaluation of Elderly Patients in Home Care Within the Brazilian Private Health Sector: A Retrospective Study

    Dec 1, 2025, 00:00

  • Value-Based Commissioning of Mental Health Services in England: A Feasibility Study Using Multicriteria Decision Analysis

    Dec 1, 2025, 00:00

  • HSD6 Analysis of Pharmacists' Awareness on Post COVID-19 Conditions and Implementation in Postgraduate Education in Ukraine

    Dec 1, 2025, 00:00

  • EE371 Economic Evaluation in the MENA Region (2015-2025): A Targeted Review of Methodological Rigor and Policy Relevance

    Dec 1, 2025, 00:00

  • EE343 Dominance in Economic Evaluation as a Leverage in Pharmaceutical Price Negotiation

    Dec 1, 2025, 00:00

  • EE337 Disease Management Costs in Late-Line Metastatic Colorectal Cancer: A Portuguese Perspective Using Structured Expert Elicitation

    Dec 1, 2025, 00:00

  • P48 Empirical Comparison of Subjective Well-Being and Health-Related Quality of Life Measures in Australian Adolescents

    Dec 1, 2025, 00:00

  • EPH61 Development of an Indicator-Based Framework for Epidemic Phase Classification in Emerging Respiratory Infectious Diseases

    Dec 1, 2025, 00:00

  • EE190 Cost Comparison of Alternative Delivery Routes for Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RA) in the English National Health Service (NHS)

    Dec 1, 2025, 00:00

  • MSR56 Comparative Evaluation of Sequence-Encoding Strategies for Clustering Inhaled Therapy Pathways in COPD Patients Using Real-World Data

    Dec 1, 2025, 00:00

  • HTA314 The Development of the Multicriteria Decision Analysis in Specialized Burn Care: The Methodological Process

    Dec 1, 2025, 00:00

  • HTA274 Pricing Analysis of Value-Added Medicines (VAMs) in Europe: A Call for Recognition of Patient-Centric Innovation

    Dec 1, 2025, 00:00

  • EE114 Budget Impact of the VELYS™ Robotic-Assisted Solution Compared to Manual Procedure in Patients Undergoing Primary Total Knee Arthroplasty in Spain

    Dec 1, 2025, 00:00

  • RWD117 Leveraging Large Language Models and EMR Data to Identify Undiagnosed Rare Diseases: A Hybrid AI Approach

    Dec 1, 2025, 00:00

  • EPH268 Underlying Systemic Motifs That Prevent Diabetes Patients From Seeking and Utilizing Health Services in a Country With a High Prevalence of Diabetes

    Dec 1, 2025, 00:00

  • EE6 A Comparison of Treatment Costs for CDK4/6 Inhibitors in Patients With Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative HR+/HER2-: Early Breast Cancer (EBC) in Sweden

    Dec 1, 2025, 00:00

  • HPR72 EU HTA, Joint Clinical Assessment, and JCA Report: What Is the Possible Impact on Price Negotiation for Orphan Drugs in Germany?

    Dec 1, 2025, 00:00

  • RWD65 Disease Management in Adults with Type 1 Diabetes Who Have a Prior Type 2 Diabetes Misdiagnosis and Recorded HbA1c in a US Managed Care Population

    Dec 1, 2025, 00:00

  • SA107 Zero-Shot RCT Identification Using Large Language Models: A Comparative Study With the Cochrane Classifier

    Dec 1, 2025, 00:00

  • EE397 Economic Impact of Emicizumab vs. On-Demand Therapy With Bypassing Agents in Patients With Hemophilia A With Inhibitors in Mexico

    Dec 1, 2025, 00:00

  • EE267 Cost-Effectiveness of Peripheral Neuropathy Screening in Malaysian Adults With Thalassemia: An Integrated Modeling Approach

    Dec 1, 2025, 00:00

  • OP21 Scientific Outcome of ISPOR Conferences: An Analysis of 67,055 Abstracts Presented at 54 ISPOR Conferences Between 2002-2024

    Dec 1, 2025, 00:00

  • EE150 Conceptual Approach to Economic Modeling in Retinal Diseases: A Review and Critique of Two NICE Clinical Guidelines

    Dec 1, 2025, 00:00

  • HPR101 From Cost Containment to Modernization: Market Access Updates Across the EU4 and the UK in 2025

    Dec 1, 2025, 00:00

  • HTA340 Transportability of Overall Survival in Multiple Myeloma From the US to Germany: A Benchmarking Study

    Dec 1, 2025, 00:00

  • EE744 Unlocking Value: Assessing the Cost-Effectiveness of Pitolisant Wakix®in Portugal

    Dec 1, 2025, 00:00

  • HTA210 Integration of Germany’s AMNOG Framework With the Joint Clinical Assessment Process

    Dec 1, 2025, 00:00

  • OP7 Exploring Value in Healthcare: Patient Satisfaction in Spain Before and After the Pandemic

    Dec 1, 2025, 00:00

  • EE525 Impact of Anosmia Severity on Health Utility Values in Chronic Rhinosinusitis With Nasal Polyps: An Exploratory Analysis From the WAYPOINT Trial

    Dec 1, 2025, 00:00

  • P2 Can AI-Assisted Data Extraction From HTA Reports Improve Comparative HTA Research: A Case Study on NICE Assessment Reports

    Dec 1, 2025, 00:00

  • EE201 Cost-Effectiveness Analysis of GAAD Algorithm for Hepatocellular Carcinoma Surveillance of Cirrhotic Patients Using Italian Real-World Data

    Dec 1, 2025, 00:00

  • RWD56 Descriptive Comparison of Patient Characteristics and Treatment Patterns in Metastatic NSCLC: US and France Cohorts to Inform Transportability

    Dec 1, 2025, 00:00

  • EE323 Developing a Multi-Indication Wider Societal Value Model to Estimate the Economic Impact of Semaglutide in Canada

    Dec 1, 2025, 00:00

  • SA18 Calibrating Large Language Model Probabilities to Achieve Target Recall in Systematic Review Screening

    Dec 1, 2025, 00:00

  • CO130 Health-Related Quality of Life (HRQoL) Impacts in Individuals With Hypophosphatasia (HPP): A Systematic Literature Review (SLR)

    Dec 1, 2025, 00:00

  • EPH65 Drivers of Improvement in Observed Survival in Malignant Cancer Sites: A Cancer Registry Analysis

    Dec 1, 2025, 00:00

  • EPH263 Trends in Hospitalizations and Amputations in Diabetic Foot Ulcers (DFUs) in Germany 2019 to 2024

    Dec 1, 2025, 00:00

  • P43 Cost-Effectiveness and Budget Impact of Gene Therapy for Eligible Patients With Sickle Cell Disease in the Netherlands

    Dec 1, 2025, 00:00

  • HTA194 Impact of the Introduction of the NICE Severity Modifier on HTA Outcomes of Oncology and Non-oncology Orphan Drugs

    Dec 1, 2025, 00:00

  • RWD173 Short- and Longer-Term Healthcare Resource Utilization and Related Costs With Psoriasis in Brazilian Private Market

    Dec 1, 2025, 00:00

  • CO138 Impact of Individualized Neoantigen Therapies on Health, Productivity, and Health System Capacity Outcomes in Resected Melanoma in Belgium

    Dec 1, 2025, 00:00

  • EE41 Adjuvanted RSVpreF3 Vaccine for Respiratory Syncytial Virus Prevention in the United Kingdom, Spain, and Australia: A Climate Change Impact Analysis

    Dec 1, 2025, 00:00

  • EE635 Real-World Cost-Utility of Faricimab vs. Current and Future Anti-VEGF Therapies in Patients With Neovascular Age-Related Macular Degeneration in Italy

    Dec 1, 2025, 00:00

  • EE627 Quantifying the Fiscal Benefits of Obesity Prevalence Reduction in China: A Public Economic Perspective

    Dec 1, 2025, 00:00

  • RWD52 Data-Driven Alerts to Support the Care of People Living With Epilepsy and Provide an Infrastructure for the Development of Real-World Evidence

    Dec 1, 2025, 00:00

  • EE545 Impacts of National Medical Insurance Negotiation on Antitumor Drug Utilization and Financial Burden: A City-Level Analysis in China

    Dec 1, 2025, 00:00

  • MSR156 NICE and CDA Assessment of Artificial Intelligence-Enabled Health Technologies: Analysis and Insights

    Dec 1, 2025, 00:00

  • EPH128 Hospital Systemic Treatment for HepatoCarcinoma: The HOSTHECA Study

    Dec 1, 2025, 00:00

  • HSD101 Self-Reported Health Related Quality of Life (HRQoL) in Patients With Ischemic Heart Disease: A Randomized Controlled Trial on Digital Health Pharmacist Interventions

    Dec 1, 2025, 00:00

  • HPR45 Clinical Outcome Assessments in Drug Approvals: Trends and Insights From FDA; EMA Labeling 2018-2023

    Dec 1, 2025, 00:00

  • HPR166 Public Spending on Medicines Between 2018 and 2026: Lessons for Designing a New Financing Model in Portugal

    Dec 1, 2025, 00:00

  • MT35 Potential Impacts of Improvement in Turnaround Time

    Dec 1, 2025, 00:00

  • CO142 Impact of Tafamidis Use in Colombian Patients Diagnosed With ATTR-CM on Health-Related Quality of Life During One Year of Follow-up: Real-World Study in Colombia

    Dec 1, 2025, 00:00

  • HTA229 Maximizing Acceptance of Patient-Reported Outcome Data in German HTA Decision Making: Results From a Horizon Scan

    Dec 1, 2025, 00:00

  • EE138 Comparative Cost-Effectiveness Analysis of Isavuconazole vs. Liposomal Amphotericin B for the Treatment of Invasive Mucormycosis in Algerian Hospital Setting

    Dec 1, 2025, 00:00

  • CO54 Comparative Efficacy and Safety of Avacincaptad Pegol vs. Pegcetacoplan in Treatment of Geographic Atrophy: Insights From a Multilevel Network Meta-Regression

    Dec 1, 2025, 00:00

  • EE71 Baseline Risk Heterogeneity in Cost-Effectiveness Analysis of the Diabetes Prevention Program

    Dec 1, 2025, 00:00

  • EE448 Evaluation of the Societal Impact of Emicizumab in France Since Its Market Authorization: Budget Impact From 2018 to 2024

    Dec 1, 2025, 00:00
  • 1
  • 2
  • 3 (current)
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • »